2026 Advanced Chemical Patent Practice Institute
May 11 to 12, 2026
Location
San Francisco, CA, USA
Contact
Credits
CLE calculations pending
Registration
The Advanced Chemical & Biotech Patent Institute is an in-depth continuing legal education program tailored specifically for experienced patent practitioners in the chemical and biotech fields. This advanced course offers a comprehensive view from both prosecution and litigation perspectives, covering crucial topics relevant to practice in the U.S. and internationally.
Program Highlights:
- Advanced Patent Prosecution Techniques: Master the nuances of preparing and prosecuting patent applications effectively from experts with 20+ years of experience.
- Navigating Legal Challenges: Explore the complexities of written description from both U.S. and global perspectives and learn strategies to withstand challenges from the PTAB and the courts.
- Optimize Your Patent Practice: Understand and adapt to changes stemming from recent legislative updates and USPTO guidelines.
- Due Diligence in View of Current Case Law: Gain insights into conducting thorough due diligence, considering the latest developments in case law.
- Leveraging AI Tools: Discover how to utilize AI technologies to enhance efficiency and optimize your patent practice.
- Client Counseling and Strategic Decisions: Enhance your ability to counsel clients effectively and make informed strategic portfolio and business decisions.
Don't miss this opportunity to elevate your practice and stay ahead in the dynamic fields of Chemical and Biotech patent law.
If you plan on attending the Spring Meeting, there is special pricing for this event. You must register for the Spring Meeting at the same time.
If you only want to attend the 2026 Advanced Chemical Patent Practice Institute, select this event and click "Individual Registration".
________________________________________________________________________________________________________________________
News
-
AIPLA Comments to USPTO on PTAB NPRM
December 3, 2025
Arlington, VA. December 2, 2025 - The American Intellectual Property Law Association (AIPLA) submitted comments in response to the USPTO's October 17, 2025, Notice of Proposed Rulemaking on Revisions to the PTAB's Rules of Practice. -
AIPLA Comments to UK IPO on Designs Framework Consultation
December 1, 2025
Arlington, VA. November 25, 2025 - The American Intellectual Property Law Association (AIPLA) submitted comments in response to the UK IPO’s Designs Consultation published in September 2025 (the “Consultation”). -
Letter in Support - S. 1546 - Patent Eligibility Restoration Act
October 8, 2025
Arlington, VA. October 8, 2025 - The American Intellectual Property Law Association (AIPLA) submitted a letter in support for S. 1546, the Patent Eligibility Restoration Act. -
AIPLA Comments on the UK IPO’s Standards Essential Patents Consultation
October 7, 2025
Arlington, VA. October 7, 2025 – The American Intellectual Property Law Association (AIPLA) submitted comments to the UK Intellectual Property Office (UK IPO) regarding its Standards Essential Patents (SEP) Consultation published in July 2025. AIPLA expressed support for the UK IPO’s goal of improving predictability and efficiency in SEP licensing but emphasized the need for a balanced approach that protects both SEP holders and implementers. -
US Senate Confirms John A. Squires as Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office
September 18, 2025
On September 18, 2025, the U.S. Senate confirmed John A. Squires as Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office.
